insulinotropic peptide insulinotropic peptide - Glucose dependentinsulinotropic peptideand gastric inhibitorypeptide peptide Understanding Insulinotropic Peptide: A Key Regulator of Glucose Metabolism

Glucose-dependentinsulinotropic peptideexamples Insulinotropic peptide, more commonly known as glucose-dependent insulinotropic polypeptide (GIP), plays a crucial role in regulating glucose metabolismGastric inhibitory polypeptide. This peptide is a significant member of the incretin family of hormones, primarily secreted by enteroendocrine cells in the upper small intestine.Novo combination obesity shot meets goal in diabetes trial Its primary function is to enhance insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning it only stimulates insulin release when blood glucose levels are elevated, typically after a meal.

Historically, GIP was initially identified as gastric inhibitory peptide, a term reflecting its early-observed effect of inhibiting gastric acid secretion. However, extensive research over the decades has revealed its more potent and primary role in glucose homeostasis, leading to its current designation as glucose-dependent insulinotropic polypeptide. This evolution in understanding underscores the importance of ongoing scientific inquiry in fully elucidating the functions of biological molecules.作者：C Zhou·2025·被引用次数：2—Glucose-dependentinsulinotropic peptide(GIP), a key incretin hormone, has emerged as a pivotal therapeutic target in metabolic disorders.

The Mechanism of Action and Physiological Significance

Upon ingestion of food, particularly carbohydrates and fats, GIP is released into the bloodstreamPhysiology, Gastric Inhibitory Peptide - StatPearls - NCBI - NIH. It then circulates to the pancreas, where it binds to specific GIP receptors (GIPR) on the surface of pancreatic beta cells. This binding triggers a cascade of intracellular signaling events that significantly amplify glucose-stimulated insulin secretion. This insulinotropic effect is critical for preventing hyperglycemia after mealsGlucose-Dependent Insulinotropic Polypeptide in Incretin Physiology.

Beyond its direct impact on insulin release, GIP also influences other aspects of metabolism. It has been shown to promote adipocyte differentiation and lipid accumulation, contributing to energy storageGlucose-Dependent Insulinotropic Polypeptide Protein .... Furthermore, GIP plays a role in regulating glucagon-like peptide-1 (GLP-1), another key incretin hormone. While both GIP and GLP-1 are involved in glucose control, their interplay is complex. In healthy individuals, GIP is the predominant incretin hormone, responsible for the majority of the incretin effect. However, in individuals with type 2 diabetes, the insulin response to GIP secretion is significantly impaired, while the response to GLP-1 often remains more intact. This differential response has significant implications for therapeutic strategies.

GIP in Metabolic Disorders and Therapeutic Potential

The understanding of glucose-dependent insulinotropic polypeptide's role in metabolic diseases, particularly type 2 diabetes and obesity, has led to its emergence as a pivotal therapeutic targetGlucose-dependent insulinotropic polypeptide (GIP) .... Research indicates that impaired GIP signaling or function can contribute to the pathogenesis of these conditions.

The development of GLP-1 receptor agonists has revolutionized the treatment of type 2 diabetes and obesity. More recently, significant advancements have been made in developing dual agonists that target both GLP-1 and GIP receptorsGlucose-dependent insulinotropic polypeptide (GIP) .... Tirzepatide, for instance, is a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist that has demonstrated remarkable efficacy in clinical trials for both type 2 diabetes and obesity managementGlucose-dependent Insulinotropic Polypeptide (GIP). Co-agonists are being explored for their enhanced therapeutic potential in treating metabolic diseases, offering a more comprehensive approach to managing conditions like obesity.

Conversely, research into GIPR antagonists also holds therapeutic promise as anti-diabetic and anti-obesity agents. These antagonists aim to block the action of GIP, potentially offering an alternative or complementary strategy to agonistic approaches.

Research and Diagnostic Applications

The study of insulinotropic peptide extends to its involvement in carbohydrate disorders. Its levels can serve as potential biomarkers in certain conditions作者：Y Seino·2013·被引用次数：328—Abstract. Glucose-dependentinsulinotropic polypeptide(GIP) and glucagon-like peptide-1 (GLP-1) are the two primary incretin hormones secreted .... For instance, studies have explored the association of glucose-dependent insulinotropic peptide levels with increased carotid intima-media thickness, suggesting potential links to cardiovascular health.The dual glucose-dependent insulinotropic polypeptide ...

For research purposes, methods like solid-phase sandwich ELISA are employed for the precise determination of active forms of human GIP in biological samples, such as EDTA-plasma. This allows for detailed investigations into GIP secretion, metabolism, and receptor interactions, contributing to a deeper understanding of its physiological roles and pathophysiological implications. The availability of purified GIP protein, often supplied as a lyophilized powder, facilitates various immunochemical applications and research experimentsRoche Announces Positive Topline Results from Phase II ....

In summary, insulinotropic peptide, or glucose-dependent insulinotropic polypeptide (GIP), is a vital hormone intricately involved in glucose metabolism.GIP: Glucose-dependent Insulinotropic Peptide Its discovery and subsequent detailed characterization have unveiled its significant impact on insulin secretion and its broader implications in metabolic health.作者：Y Seino·2013·被引用次数：328—Abstract. Glucose-dependentinsulinotropic polypeptide(GIP) and glucagon-like peptide-1 (GLP-1) are the two primary incretin hormones secreted ... The ongoing development of therapeutic strategies targeting the GIP pathway highlights its critical importance and continued relevance in addressing the growing global burden of diabetes and obesity.